Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05180942 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS

Study acronym: SOCRATES
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Jun 2026 → Dec 2026
See other at-risk trials from Monash University

Record History

  1. Enrollment closed, study ongoing Primary and study completion pushed from Jun 2026 to Dec 2026 · Eligibility criteria expanded, about 14 words · Secondary endpoints: details revised at 1 of 7 entries · 1 more Show 4 more changesShow less
    • Primary and study completion pushed from Jun 2026 to Dec 2026
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 1 of 7 entries
    • Site details revised at 12 of 12 sites
  2. Study sites: 10 to 12v11
  3. Study sites: 9 to 10v10
  4. Study sites: 8 to 9v9
  5. Study sites: 7 to 8v8
Show 6 earlier versionsHide 6 earlier versions
  1. Phase: Phase 2 to Not specified Primary endpoint revised · Enrollment target: 180 to 130 · Study sites: 3 to 7 · 2 morev7 Show 5 more changesShow less
    • Primary endpoint revised
    • Enrollment target: 180 to 130
    • Study sites: 3 to 7
    • Eligibility criteria expanded, about 88 words
    • Secondary endpoints: 10 to 7

    See this version in full on ClinicalTrials.gov ↗

  2. Primary and study completion dates: Jun 2025 to Jun 2026 Eligibility criteria shortened, about 1 wordv6 Show 1 more changeShow less
    • Eligibility criteria shortened, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  3. Study sites: 1 to 3v5
  4. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Oct 2022 to Nov 7, 2022 · Site details revisedv4 Show 2 more changesShow less
    • Start date changed from estimate of Oct 2022 to Nov 7, 2022
    • Site details revised
  5. Start date: May 2022 to Oct 2022v3
  6. Start date: Feb 2022 to May 2022 Secondary endpoints revised (10)v2 Show 1 more changeShow less
    • Secondary endpoints revised (10)

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Monash University
29 trials monitored
See 3 trials at risk
Melanoma
1,026 trials monitored
See 48 trials at risk
This study is a prospective observational study evaluating the natural history of coronary plaque burden in participants with melanoma treated with ICI. The study will be conducted at various sites across Australia.
Trial Details
NCT Number NCT05180942
Lead Sponsor Monash University
Collaborators: National Health and Medical Research Council, Australia
Conditions Melanoma, Atherosclerosis
Enrollment 130 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov